Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - dímetýl fúmarat - margvísleg sclerosis - Ónæmisbælandi lyf - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
skilarence
almirall s.a - dímetýl fúmarat - psoriasis - Ónæmisbælandi lyf - skilaréttur er ætlaður til meðferðar á miðlungsmiklum til alvarlegum skellupsoriasis hjá fullorðnum sem þurfa á almennri lyfjameðferð.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
minifom dropar til inntöku, fleyti 100 mg/ml
aco hud nordic ab* - antifoam m - dropar til inntöku, fleyti - 100 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
creon (pankreon) magasýruþolið hart hylki 10.000
viatris aps - pancreatinum - magasýruþolið hart hylki - 10.000
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
exelon (lyfjaver) forðaplástur 4,6 mg/24 klst.
lyfjaver ehf. - rivastigminum inn - forðaplástur - 4,6 mg/24 klst.